[Advances in the field of liver diseases].
D000208:Acute Disease; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D002908:Chronic Disease; D004357:Drug Synergism; D004790:Enzyme Induction; D000431:Ethanol / Q000009:adverse effects; D006506:Hepatitis A / Q000097:blood / Q000150:complications; D006509:Hepatitis B / Q000097:blood / Q000209:etiology / Q000382:microbiology / Q000517:prevention & control; D006511:Hepatitis B Antigens / Q000032:analysis; D006801:Humans; D007110:Immunity, Active; D007114:Immunization; D008099:Liver / Q000187:drug effects; D008107:Liver Diseases / Q000175:diagnosis*; D010634:Phenobarbital / Q000009:adverse effects; D011379:Prognosis
D006511:Hepatitis B Antigens; D000431:Ethanol; D010634:Phenobarbital
Fortschritte auf dem Gebiet der Leberkrankheiten